AbbVie Inc (NYSE: ABBV) Avoids Lawsuit Over Alzheimer’s Drugs Patent Fraud

For the time being, AbbVie Inc (NYSE: ABBV) has dodged a whistleblower suit asserting that its predecessor Allergan Inc. extended its exclusivity on Alzheimer’s medications by using false patents, enabling it to defraud Medicaid and Medicare. Silbersher filed a claim using publicly available information  Zachary Silbersher, a prominent associate at the IP rights litigation organization Kroub, […]